320 related articles for article (PubMed ID: 22238244)
21. Sicca/Sjögren's syndrome triggered by PD-1/PD-L1 checkpoint inhibitors. Data from the International ImmunoCancer Registry (ICIR).
Ramos-Casals M; Maria A; Suárez-Almazor ME; Lambotte O; Fisher BA; Hernández-Molina G; Guilpain P; Pundole X; Flores-Chávez A; Baldini C; Bingham Iii CO; Brito-Zerón P; Gottenberg JE; Kostine M; Radstake TRD; Schaeverbeke T; Schulze-Koops H; Calabrese L; Khamashta MA; Mariette X;
Clin Exp Rheumatol; 2019; 37 Suppl 118(3):114-122. PubMed ID: 31464670
[TBL] [Abstract][Full Text] [Related]
22. Characterization of systemic disease in primary Sjögren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements.
Ramos-Casals M; Brito-Zerón P; Seror R; Bootsma H; Bowman SJ; Dörner T; Gottenberg JE; Mariette X; Theander E; Bombardieri S; De Vita S; Mandl T; Ng WF; Kruize A; Tzioufas A; Vitali C;
Rheumatology (Oxford); 2015 Dec; 54(12):2230-8. PubMed ID: 26231345
[TBL] [Abstract][Full Text] [Related]
23. Primary Sjögren's syndrome: Extraglandular manifestations and hydroxychloroquine therapy.
Demarchi J; Papasidero S; Medina MA; Klajn D; Chaparro Del Moral R; Rillo O; Martiré V; Crespo G; Secco A; Catalan Pellet A; Amitrano C; Crow C; Asnal C; Pucci P; Caeiro F; Benzanquen N; Pirola JP; Mayer M; Zazzetti F; Velez S; Barreira J; Tamborenea N; Santiago L; Raiti L
Clin Rheumatol; 2017 Nov; 36(11):2455-2460. PubMed ID: 28913747
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of primary Sjögren's syndrome in China.
Zhang NZ; Shi CS; Yao QP; Pan GX; Wang LL; Wen ZX; Li XC; Dong Y
J Rheumatol; 1995 Apr; 22(4):659-61. PubMed ID: 7791159
[TBL] [Abstract][Full Text] [Related]
25. The clinical features of Sjögren's syndrome in Japanese children.
Tomiita M; Saito K; Kohno Y; Shimojo N; Fujikawa S; Niimi H
Acta Paediatr Jpn; 1997 Apr; 39(2):268-72. PubMed ID: 9141270
[TBL] [Abstract][Full Text] [Related]
26. The prevalence of Sjögren’s syndrome and sicca symptoms in patients with systemic sclerosis and alpha-smooth muscle actin expression in biopsy specimens from minor salivary glands.
Can G; Sarıoğlu S; Birlik M; Kenar G; Soysal Ö; Solmaz D; Gerdan V; Önen F; Akkoç N; Akar S
Turk J Med Sci; 2021 Aug; 51(4):1875-1882. PubMed ID: 33773524
[TBL] [Abstract][Full Text] [Related]
27. Severe, life-threatening phenotype of primary Sjögren's syndrome: clinical characterisation and outcomes in 1580 patients (GEAS-SS Registry).
Flores-Chávez A; Kostov B; Solans R; Fraile G; Maure B; Feijoo-Massó C; Rascón FJ; Pérez-Alvarez R; Zamora-Pasadas M; García-Pérez A; Lopez-Dupla M; Duarte-Millán MÁ; Ripoll M; Fonseca-Aizpuru E; Guisado-Vasco P; Pinilla B; de-la-Red G; Chamorro AJ; Morcillo C; Fanlo P; Soto-Cárdenas MJ; Retamozo S; Ramos-Casals M; Brito-Zerón P;
Clin Exp Rheumatol; 2018; 36 Suppl 112(3):121-129. PubMed ID: 30156546
[TBL] [Abstract][Full Text] [Related]
28. Risk of non-Hodgkin's lymphoma in primary Sjögren's syndrome: a population-based study.
Johnsen SJ; Brun JG; Gøransson LG; Småstuen MC; Johannesen TB; Haldorsen K; Harboe E; Jonsson R; Meyer PA; Omdal R
Arthritis Care Res (Hoboken); 2013 May; 65(5):816-21. PubMed ID: 23139233
[TBL] [Abstract][Full Text] [Related]
29. Classification criteria of Sjögren's syndrome.
Goules AV; Tzioufas AG; Moutsopoulos HM
J Autoimmun; 2014; 48-49():42-5. PubMed ID: 24456935
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of systemic activity of pediatric primary Sjögren's syndrome by EULAR Sjögren's syndrome disease activity index (ESSDAI).
Kobayashi I; Okura Y; Ueki M; Tozawa Y; Takezaki S; Yamada M; Ariga T
Mod Rheumatol; 2019 Jan; 29(1):130-133. PubMed ID: 29529894
[TBL] [Abstract][Full Text] [Related]
31. Sicca symptoms are associated with similar fatigue, anxiety, depression, and quality-of-life impairments in patients with and without primary Sjögren's syndrome.
Milin M; Cornec D; Chastaing M; Griner V; Berrouiguet S; Nowak E; Marhadour T; Saraux A; Devauchelle-Pensec V
Joint Bone Spine; 2016 Dec; 83(6):681-685. PubMed ID: 26774177
[TBL] [Abstract][Full Text] [Related]
32. [Psychiatric manifestations of lupus erythematosus systemic and Sjogren's syndrome].
Ampélas JF; Wattiaux MJ; Van Amerongen AP
Encephale; 2001; 27(6):588-99. PubMed ID: 11865567
[TBL] [Abstract][Full Text] [Related]
33. Association of Sjögren's Syndrome With Reduced Lifetime Sex Hormone Exposure: A Case-Control Study.
McCoy SS; Sampene E; Baer AN
Arthritis Care Res (Hoboken); 2020 Sep; 72(9):1315-1322. PubMed ID: 31233285
[TBL] [Abstract][Full Text] [Related]
34. Anti-SSA/SSB-negative Sjögren's syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolution.
Quartuccio L; Baldini C; Bartoloni E; Priori R; Carubbi F; Corazza L; Alunno A; Colafrancesco S; Luciano N; Giacomelli R; Gerli R; Valesini G; Bombardieri S; De Vita S
Autoimmun Rev; 2015 Nov; 14(11):1019-22. PubMed ID: 26162302
[TBL] [Abstract][Full Text] [Related]
35. [Association of systemic lupus erythematosus and Sjögren's syndrome].
Szántó A; Kiss E; Sas A; Szegedi G; Zeher M
Orv Hetil; 2005 Dec; 146(50):2533-8. PubMed ID: 16440498
[TBL] [Abstract][Full Text] [Related]
36. The SSB-positive/SSA-negative antibody profile is not associated with key phenotypic features of Sjögren's syndrome.
Baer AN; McAdams DeMarco M; Shiboski SC; Lam MY; Challacombe S; Daniels TE; Dong Y; Greenspan JS; Kirkham BW; Lanfranchi HE; Schiødt M; Srinivasan M; Umehara H; Vivino FB; Vollenweider CF; Zhao Y; Criswell LA; Shiboski CH;
Ann Rheum Dis; 2015 Aug; 74(8):1557-61. PubMed ID: 25735642
[TBL] [Abstract][Full Text] [Related]
37. Detection of xerostomia, Sicca, and Sjogren's syndromes in a national sample of adults.
Stankeviciene I; Puriene A; Mieliauskaite D; Stangvaltaite-Mouhat L; Aleksejuniene J
BMC Oral Health; 2021 Oct; 21(1):552. PubMed ID: 34706704
[TBL] [Abstract][Full Text] [Related]
38. Utility of the American-European Consensus Group and American College of Rheumatology Classification Criteria for Sjögren's syndrome in patients with systemic autoimmune diseases in the clinical setting.
Hernández-Molina G; Avila-Casado C; Nuñez-Alvarez C; Cárdenas-Velázquez F; Hernández-Hernández C; Luisa Calderillo M; Marroquín V; Recillas-Gispert C; Romero-Díaz J; Sánchez-Guerrero J
Rheumatology (Oxford); 2015 Mar; 54(3):441-8. PubMed ID: 25193805
[TBL] [Abstract][Full Text] [Related]
39. American College of Rheumatology classification criteria for Sjögren's syndrome: a data-driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance cohort.
Shiboski SC; Shiboski CH; Criswell L; Baer A; Challacombe S; Lanfranchi H; Schiødt M; Umehara H; Vivino F; Zhao Y; Dong Y; Greenspan D; Heidenreich AM; Helin P; Kirkham B; Kitagawa K; Larkin G; Li M; Lietman T; Lindegaard J; McNamara N; Sack K; Shirlaw P; Sugai S; Vollenweider C; Whitcher J; Wu A; Zhang S; Zhang W; Greenspan J; Daniels T;
Arthritis Care Res (Hoboken); 2012 Apr; 64(4):475-87. PubMed ID: 22563590
[TBL] [Abstract][Full Text] [Related]
40. Association of Anticentromere Antibodies With More Severe Exocrine Glandular Dysfunction in Sjögren's Syndrome: Analysis of the Sjögren's International Collaborative Clinical Alliance Cohort.
Baer AN; Medrano L; McAdams-DeMarco M; Gniadek TJ
Arthritis Care Res (Hoboken); 2016 Oct; 68(10):1554-9. PubMed ID: 26867144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
